James C. Byrd
- Molecular Biology top 2%
- Immunology top 2%
- Organic Chemistry top 2%
- Oncology top 5%
- Surgery top 5%
- Co-authors
- Robert S. BresalierRichard G. MacDonaldJames R. GumJames W. HicksYoung S. KimAvraham RazBader SiddikiGordon Schectman
- Topics
- Glycosylation and Glycoproteins Research (44 papers)Galectins and Cancer Biology (27 papers)Carbohydrate Chemistry and Synthesis (14 papers)
- Cited by
- ImmunologyMolecular BiologyOncology
- Journals
- Journal of Biological ChemistryJournal of Clinical InvestigationSHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
James C. Byrd
113 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 170
- Molecular Biology 3.5k
- Immunology 1.5k
- Organic Chemistry 862
- Oncology 842
- Surgery 833
Countries citing papers authored by James C. Byrd
This map shows the geographic impact of James C. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Byrd more than expected).
Fields of papers citing papers by James C. Byrd
This network shows the impact of papers produced by James C. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Byrd. The network helps show where James C. Byrd may publish in the future.
Co-authorship network of co-authors of James C. Byrd
This figure shows the co-authorship network connecting the top 25 collaborators of James C. Byrd. A scholar is included among the top collaborators of James C. Byrd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Byrd. James C. Byrd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 77 | |
| 2 | 39 | |
| 3 | 18 | |
| 4 | 24 | |
| 5 | 10 | |
| 6 | 96 | |
| 7 | Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. | 91 |
| 8 | Colon cancer mucin | 2 |
| 9 | 130 | |
| 10 | 4 | |
| 11 | 27 | |
| 12 | 4 | |
| 13 | 162 | |
| 14 | 76 | |
| 15 | 36 | |
| 16 | 23 | |
| 17 | 12 | |
| 18 | 275 | |
| 19 | 24 | |
| 20 | 14 |
About James C. Byrd
James C. Byrd is a scholar working on Immunology, Molecular Biology and Oncology, having authored 113 papers that have together received 6.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (44 papers), Galectins and Cancer Biology (27 papers) and Carbohydrate Chemistry and Synthesis (14 papers). The work is most often cited by research in Immunology (1.5k citations), Molecular Biology (3.5k citations) and Oncology (842 citations). James C. Byrd has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Robert S. Bresalier, Richard G. MacDonald, James R. Gum, James W. Hicks, Young S. Kim, Avraham Raz, Bader Siddiki, Gordon Schectman, Harvey W. Gruchow and Cathy D. Meade. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.